男性尿失禁市場：依尿失禁類型及產品類型（吸收性產品）分類

預計到 2026 年，男性尿失禁市場規模將達到 72.4 億美元，到 2033 年將達到 109.5 億美元。預計從 2026 年到 2033 年，該市場將以 6.1% 的複合年成長率成長。

全球男性尿失禁市場是整個醫療保健行業的重要組成部分，它關注的是一種常見疾病，儘管影響著全球數百萬男性，但往往未被充分報告。男性尿失禁的特徵是膀胱控制能力的喪失，涵蓋多種類型，包括應力性尿失禁、急性尿失禁、充溢性尿失禁和混合性尿失禁，每種類型都有其獨特的臨床挑戰和治療需求。雖然該疾病主要影響老年男性，且盛行率隨年齡成長而顯著增加，但前列腺手術、神經系統疾病和創傷等因素也可能影響年輕男性。

該市場涵蓋了全面的治療方案，例如可吸收產品、外用導尿管、植入式裝置、藥物療法和外科手術，旨在控制和治療尿失禁的根本原因。儘管男性尿失禁對生活品質、社交功能和心理健康有顯著影響，但它仍然受到社會歧視，導致患者診斷和治療延誤。這反過來又影響著區域市場動態和成長模式。

市場動態

全球男性尿失禁市場主要受多種相互關聯的因素所驅動，這些因素共同推動該治療領域的市場擴張和創新。全球人口老化是最重要的市場促進因素，因為尿失禁的盛行率隨著老齡化的成長而顯著增加，尤其是在65歲以上的男性中，擴大了需要治療方案的患者群體。醫療機構和支持團體活性化的宣傳宣傳活動和教育活動不斷增加，正逐步消除與男性尿失禁相關的社會污名，促使更多男性尋求專業的醫療支持和適當的治療方法。醫療設備的技術進步，包括先進的人工尿道括約肌、男性用吊帶和微創手術技術的研發，正在拓展治療選擇並改善病患的治療效果。

此外，前列腺相關疾病（包括良性前列腺增生和需要手術治療的前列腺癌）的日益普遍，直接導致男性尿失禁的發生率上升，從而推動了對預防和治療方案的需求。然而，市場成長面臨著許多限制因素，例如根深蒂固的社會污名和羞恥感，導致漏診和診斷延遲，限制了市場滲透率。治療費用高昂，尤其是複雜手術和植入式醫療設備的費用，在醫療基礎設施和保險覆蓋範圍有限的發展中地區構成了就醫的巨大障礙。醫療設備核准和藥物幹預的監管複雜性可能會延遲產品上市，並增加製造商的研發成本。儘管如此，新興市場仍蘊藏著巨大的機會。預計醫療基礎設施的改善和醫療支出的成長將為市場擴張開闢新的途徑，而對包括再生醫學和生物工程解決方案在內的新療法的持續研究有望徹底改變治療模式，並釋放尚未開發的市場潛力。

本次調查的主要特點

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球男性尿失禁市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務表現和策略。
• 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
• 這份關於男性尿失禁市場的全球報告針對的是該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過利用各種策略矩陣來分析全球男性尿失禁市場，從而簡化決策過程。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球男性尿失禁市場：依尿失禁類型分類，2021-2033年

• 應力性尿失禁
• 急性尿失禁
• 溢出性尿失禁
• 功能性尿失禁
• 混合型尿失禁（壓力性尿失禁+急迫性尿失禁）

第5章 全球男性尿失禁市場：依產品類型分類，2021-2033年

• 吸收性產品
• 外置導尿管（尿道鞘套）
• 留置導管
• 其他設備和系統

第6章 全球男性尿失禁市場：依年齡層別分類，2021-2033年

• 18-39歲
• 40-59歲
• 60-74歲
• 75歲或以上

第7章 全球男性尿失禁市場：依用途分類，2021-2033年

• 可重複使用的
• 拋棄式的

第8章 全球男性尿失禁市場：依最終用戶分類，2021-2033年

• 醫院
• 泌尿系統診所
• 居家醫療環境
• 長期照護機構/安養院
• 門診手術中心
• 其他

第9章 全球男性尿失禁市場：依通路分類，2021-2033年

• 離線
• 線上

第10章 全球男性尿失禁市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第11章 競爭格局

• Coloplast A/S
• ConvaTec Group PLC
• Hollister Incorporated
• Kimberly-Clark Corporation
• Medtronic PLC
• Boston Scientific Corporation
• Braun Melsungen AG
• Teleflex Incorporated
• Wellspect HealthCare
• Procter and Gamble Co.
• AbbVie Inc.
• Pfizer Inc.
• Laboratoires URGO
• Ontex Healthcare
• R. Bard（BD）

第12章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第13章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Male Urinary Incontinence Market is estimated to be valued at USD 7.24 Bn in 2026 and is expected to reach USD 10.95 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.

The global male urinary incontinence market represents a critical segment within the broader healthcare industry, addressing a prevalent yet often underreported condition affecting millions of men worldwide. Male urinary incontinence, characterized by the involuntary loss of bladder control, encompasses various types including stress incontinence, urge incontinence, overflow incontinence, and mixed incontinence, each presenting unique clinical challenges and treatment requirements. This condition predominantly affects older men, with prevalence rates increasing significantly with age, though it can also impact younger individuals due to factors such as prostate surgery, neurological disorders, or traumatic injuries.

The market encompasses a comprehensive range of therapeutic solutions including absorbent products, external catheters, implantable devices, pharmaceutical interventions, and surgical procedures designed to manage or treat the underlying causes of incontinence. Despite the significant impact on quality of life, social functioning, and psychological well-being, male urinary incontinence remains stigmatized, leading to underdiagnosis and delayed treatment seeking behavior among affected individuals, which consequently influences market dynamics and growth patterns across different geographical regions.

Market Dynamics

The global male urinary incontinence market is primarily driven by several interconnected factors that collectively propel market expansion and innovation within this therapeutic area. The aging global population serves as the most significant market driver, as the prevalence of urinary incontinence increases substantially with age, particularly among men over 65 years, creating a growing patient pool requiring management solutions. Rising awareness campaigns and educational initiatives by healthcare organizations and advocacy groups are gradually reducing the stigma associated with male incontinence, encouraging more men to seek professional medical help and appropriate treatment options. Technological advancements in medical devices, including the development of sophisticated artificial urinary sphincters, male slings, and minimally invasive surgical techniques, are expanding treatment possibilities and improving patient outcomes.

Additionally, the increasing prevalence of prostate-related disorders, including benign prostatic hyperplasia and prostate cancer requiring surgical intervention, directly contributes to the incidence of male urinary incontinence, thereby driving demand for both preventive and therapeutic solutions. However, market growth faces significant restraints including persistent social stigma and embarrassment associated with the condition, leading to underreporting and delayed diagnosis, which limits market penetration. High treatment costs, particularly for advanced surgical procedures and implantable devices, pose substantial barriers to access, especially in developing regions with limited healthcare infrastructure and insurance coverage. Regulatory complexities surrounding medical device approvals and pharmaceutical interventions can delay product launches and increase development costs for manufacturers. Nevertheless, substantial opportunities exist within emerging markets where improving healthcare infrastructure and increasing healthcare expenditure create new avenues for market expansion, while ongoing research into novel therapeutic approaches, including regenerative medicine and bioengineered solutions, promises to revolutionize treatment paradigms and capture untapped market potential.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global male urinary incontinence market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Coloplast A/S, ConvaTec Group PLC, Hollister Incorporated, Kimberly-Clark Corporation, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Wellspect HealthCare, Procter and Gamble Co., AbbVie Inc., Pfizer Inc., Laboratoires URGO, Ontex Healthcare, and C. R. Bard (BD).
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global male urinary incontinence market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global male urinary incontinence market.

Market Segmentation

• Type of Incontinence Insights (Revenue, USD Bn, 2021 - 2033)
• Stress Urinary Incontinence
• Urge Urinary Incontinence
• Overflow Urinary Incontinence
• Functional Urinary Incontinence
• Mixed Incontinence (Stress + Urge)
• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
• Absorbent Products
  • Pads and Guards
  • Adult Diapers
  • Protective Underwear
  • Bed Protectors and Mattress Covers
• External Catheters (Urinary Sheaths)
  • Latex Sheaths
  • Silicone Sheaths
  • Hydrocolloid Sheaths
• Internal Catheters
  • Indwelling (Foley) Catheters
  • Intermittent Catheters
• Other Devices and Systems
  • Male Slings
  • Artificial Urinary Sphincters
  • Electrical Stimulation Devices/Penile Clamps
• Age Group Insights (Revenue, USD Bn, 2021 - 2033)
• 18-39 Years
• 40-59 Year
• 60-74 Years
• 75 Years and Above
• Usage Type Insights (Revenue, USD Bn, 2021 - 2033)
• Reusable
• Disposable
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Hospitals
• Urology Clinics
• Home Healthcare Settings
• Long-Term Care Centers / Nursing Homes
• Ambulatory Surgical Centers
• Others
• Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
• Offline
• Online
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Coloplast A/S
• ConvaTec Group PLC
• Hollister Incorporated
• Kimberly-Clark Corporation
• Medtronic PLC
• Boston Scientific Corporation
• Braun Melsungen AG
• Teleflex Incorporated
• Wellspect HealthCare
• Procter and Gamble Co.
• AbbVie Inc.
• Pfizer Inc.
• Laboratoires URGO
• Ontex Healthcare
• R. Bard (BD)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Male Urinary Incontinence Market, By Type of Incontinence
  • Global Male Urinary Incontinence Market, By Product Type
  • Global Male Urinary Incontinence Market, By Age Group
  • Global Male Urinary Incontinence Market, By Usage Type
  • Global Male Urinary Incontinence Market, By End User
  • Global Male Urinary Incontinence Market, By Distribution Channel

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Male Urinary Incontinence Market, By Type of Incontinence, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Stress Urinary Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Urge Urinary Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Overflow Urinary Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Functional Urinary Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Mixed Incontinence (Stress + Urge)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Male Urinary Incontinence Market, By Product Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Absorbent Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Pads and Guards
      • Adult Diapers
      • Protective Underwear
      • Bed Protectors and Mattress Covers
• External Catheters (Urinary Sheaths)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Latex Sheaths
      • Silicone Sheaths
      • Hydrocolloid Sheaths
• Internal Catheters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Indwelling (Foley) Catheters
    • Intermittent Catheters
• Other Devices and Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Male Slings
      • Artificial Urinary Sphincters
      • Electrical Stimulation Devices/Penile Clamps

6. Global Male Urinary Incontinence Market, By Age Group, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• 18-39 Years
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• 40-59 Year
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• 60-74 Years
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• 75 Years and Above
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Male Urinary Incontinence Market, By Usage Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Reusable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Disposable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Male Urinary Incontinence Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Urology Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Home Healthcare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Long-Term Care Centers / Nursing Homes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Male Urinary Incontinence Market, By Distribution Channel, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Offline
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Online
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Male Urinary Incontinence Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Sub-region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Coloplast A/S
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ConvaTec Group PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hollister Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kimberly-Clark Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Wellspect HealthCare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Procter and Gamble Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Laboratoires URGO
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ontex Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• R. Bard (BD)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us